Olfactory phenotypic spectrum in idiopathic hypogonadotropic hypogonadism: Pathophysiological and genetic implications

Journal of Clinical Endocrinology and Metabolism

Volumn 97, Issue 1, 2012, Pages

  Lewkowitz Shpuntoff, Hilana M ^a   Hughes, Virginia A ^a   Plummer, Lacey ^a   Au, Margaret G ^a   Doty, Richard L ^b   Seminara, Stephanie B ^a   Chan, Yee Ming ^a,d   Pitteloud, Nelly ^c   Crowley, William F ^a   Balasubramanian, Ravikumar ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

^d BOSTON CHILDREN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANOSMIN 1; FIBROBLAST GROWTH FACTOR; FIBROBLAST GROWTH FACTOR 8; FIBROBLAST GROWTH FACTOR RECEPTOR 1; G PROTEIN COUPLED RECEPTOR 54; GONADORELIN; GONADORELIN RECEPTOR; METASTIN; NASAL EMBRYONIC LHRH FACTOR; PROKINETICIN 2; PROKINETICIN RECEPTOR 2; TACHYKININ 3; TACHYKININ RECEPTOR 3; UNCLASSIFIED DRUG;

ADULT; ANOSMIA; ARTICLE; CELL MIGRATION; COHORT ANALYSIS; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DEVELOPMENTAL GENE; DNA SEQUENCE; FEMALE; FGF8 GENE; FGFR1 GENE; GENE MUTATION; GENETIC ANALYSIS; GENETIC DISORDER; GNRH1 GENE; GNRHR GENE; HETEROZYGOSITY; HORMONE RELEASE; HUMAN; HYPOGONADOTROPIC HYPOGONADISM; HYPOSMIA; IDIOPATHIC DISEASE; IDIOPATHIC HYPOGONADOTROPIC HYPOGONADISM; KAL1 GENE; KISS1 GENE; KISS1R GENE; MAJOR CLINICAL STUDY; MALE; MONOGENIC DISORDER; NELF GENE; NERVE CELL; NEUROPATHOLOGY; NORMOSMIA; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOPHYSIOLOGY; PHENOTYPE; PRIORITY JOURNAL; PROK2 GENE; PROKR2 GENE; SCORING SYSTEM; SMELL AND TASTE PARAMETERS; SMELL IDENTIFICATION TEST; SMELLING; TAC3 GENE; TAC3R GENE; UNIVERSITY HOSPITAL;

EID: 84855473428     PISSN: 0021972X     EISSN: 19457197     Source Type: Journal    
DOI: 10.1210/jc.2011-2041     Document Type: Article

References (40)

1. Hoffman AR, Crowley Jr WF 1982 Induction of puberty in men by long-term pulsatile administration of low-dose gonadotropin-releasing hormone. N Engl J Med 307:1237-1241
2. Kallmann F, Schoenfeld W, Barrera S 1944 The genetic aspects of primary eunuchoidism. Am J Ment Defic 48:203-236
3. Schwanzel-Fukuda M, Pfaff DW 1989 Origin of luteinizing hormone-releasing hormone neurons. Nature 338:161-164
4. Legouis R, Hardelin JP, Levilliers J, Claverie JM, Compain S, Wunderle V, Millasseau P, Le Paslier D, Cohen D, Caterina D, Bougueleret L, Delemarre-Van de Waal H, Lutfalla G, Weissenbach J, Petit C 1991 The candidate gene for the X-linked Kallmann syndrome encodes a protein related to adhesion molecules. Cell 67:423-435
5. Franco B, Guioli S, Pragliola A, Incerti B, Bardoni B, Tonlorenzi R, Carrozzo R, Maestrini E, Pieretti M, Taillon-Miller P, Brown CJ, Willard HF, Lawrence C, Graziella Persico M, Camerino G, Ballabio A 1991 A gene deleted in Kallmann's syndrome shares homology with neural cell adhesion and axonal path-finding molecules. Nature 353:529-536
6. Dodé C, Levilliers J, Dupont JM, De Paepe A, Le DÛ N, Soussi- Yanicostas N, Coimbra RS, Delmaghani S, Compain-Nouaille S, Baverel F, Pêcheux C, Le Tessier D, Cruaud C, Delpech M, Speleman F, Vermeulen S, Amalfitano A, Bachelot Y, Bouchard P, Cabrol S, Carel JC, Delemarre-van de Waal H, Goulet-Salmon B, Kottler ML, Richard O, Sanchez-Franco F, Saura R, Young J, Petit C, Hardelin JP 2003 Loss-of-function mutations in FGFR1 cause autosomal dominant Kallmann syndrome. Nat Genet 33:463-465
7. Pitteloud N, Acierno Jr JS, Meysing A, Eliseenkova AV, Ma J, Ibrahimi OA, Metzger DL, Hayes FJ, Dwyer AA, Hughes VA, Yialamas M, Hall JE, Grant E, Mohammadi M, Crowley Jr WF 2006 Mutations in fibroblast growth factor receptor 1 cause both Kallmann syndrome and normosmic idiopathic hypogonadotropic hypogonadism. Proc Natl Acad Sci USA 103:6281-6286
8. Falardeau J, Chung WC, Beenken A, Raivio T, Plummer L, Sidis Y, Jacobson-Dickman EE, Eliseenkova AV, MaJ, Dwyer A, Quinton R, Na S, Hall JE, Huot C, Alois N, Pearce SH, Cole LW, Hughes V, Mohammadi M, Tsai P, Pitteloud N 2008 Decreased FGF8 signaling causes deficiency of gonadotropin-releasing hormone in humans and mice. J Clin Invest 118:2822-2831
9. Dodé C, Teixeira L, Levilliers J, Fouveaut C, Bouchard P, Kottler ML, Lespinasse J, Lienhardt-Roussie A, Mathieu M, Moerman A, Morgan G, Murat A, Toublanc JE, Wolczynski S, Delpech M, Petit C, Young J, Hardelin JP 2006 Kallmann syndrome: mutations in the genes encoding prokineticin-2 and prokineticin receptor-2. PLoS Genet 2:e175
10. Pitteloud N, Zhang C, Pignatelli D,Li JD, Raivio T, Cole LW, Plummer L, Jacobson-Dickman EE, Mellon PL, Zhou QY, Crowley Jr WF 2007 Loss-of-function mutation in the prokineticin 2 gene causes Kallmann syndrome and normosmic idiopathic hypogonadotropic hypogonadism. Proc Natl Acad Sci USA 104:17447-17452
11. Cole LW, Sidis Y, Zhang C, Quinton R, Plummer L, Pignatelli D, Hughes VA, Dwyer AA, Raivio T, Hayes FJ, Seminara SB, Huot C, Alos N, Speiser P, Takeshita A, Van Vliet G, Pearce S, Crowley Jr WF, Zhou QY, Pitteloud N 2008 Mutations in prokineticin 2 and prokineticin receptor 2 genes in human gonadotrophin- releasing hormone deficiency: molecular genetics and clinical spectrum. J Clin Endocrinol Metab 93:3551-3559
12. Abreu AP, Trarbach EB, de Castro M, Frade Costa EM, Versiani B, Matias Baptista MT, Garmes HM, Mendonca BB, Latronico AC 2008 Loss-of-function mutations in the genes encoding prokineticin-2 or prokineticin receptor-2 cause autosomal recessive Kallmann syndrome. J Clin Endocrinol Metab 93:4113-4118
13. Sarfati J, Guiochon-Mantel A, Rondard P, Arnulf I, Garcia-Piñero A, Wolczynski S, Brailly-Tabard S, Bidet M, Ramos-Arroyo M, Mathieu M, Lienhardt-Roussie A, Morgan G, Turki Z, Bremont C, Lespinasse J, Du Boullay H, Chabbert-Buffet N, Jacquemont S, Reach G, De Talence N, Tonella P, Conrad B, Despert F, Delobel B, Brue T, Bouvattier C, Cabrol S, Pugeat M, Murat A, Bouchard P, Hardelin JP, Dodé C, Young J 2010 A comparative phenotypic study of Kallmann syndrome patients carrying monoallelic and biallelic mutations in the prokineticin 2 or prokineticin receptor 2 genes. J Clin Endocrinol Metab 95:659-669
14. Kim HG, Kurth I, Lan F, Meliciani I, Wenzel W, Eom SH, Kang GB, Rosenberger G, Tekin M, Ozata M, Bick DP, Sherins RJ, Walker SL, Shi Y, Gusella JF, Layman LC 2008 Mutations in CHD7, encoding a chromatin-remodeling protein, cause idiopathic hypogonadotropic hypogonadism and Kallmann syndrome. Am J Hum Genet 83:511-519
15. de Roux N, Young J, Misrahi M, Genet R, Chanson P, Schaison G, Milgrom E 1997 A family with hypogonadotropic hypogonadism and mutations in the gonadotropin-releasing hormone receptor. N Engl J Med 337:1597-1602
16. Layman LC, Cohen DP, Jin M, Xie J, Li Z, Reindollar RH, Bolbolan S, Bick DP, Sherins RR, Duck LW, Musgrove LC, Sellers JC, Neill JD 1998 Mutations in gonadotropin-releasing hormone receptor gene cause hypogonadotropic hypogonadism. Nat Genet 18:14-15
17. Seminara SB, Messager S, Chatzidaki EE, Thresher RR, Acierno Jr JS, Shagoury JK, Bo-Abbas Y, Kuohung W, Schwinof KM, Hendrick AG, Zahn D, Dixon J, Kaiser UB, Slaugenhaupt SA, Gusella JF, O'Rahilly S, Carlton MB, Crowley Jr WF, Aparicio SA, Colledge WH 2003 The GPR54 gene as a regulator of puberty.NEngl J Med 349:1614-1627
18. Topaloglu AK, Reimann F, Guclu M, Yalin AS, Kotan LD, Porter KM, Serin A, Mungan NO, Cook JR, Ozbek MN, Imamoglu S, Akalin NS, Yuksel B, O'Rahilly S, Semple RK 2009 TAC3 and TACR3 mutations in familial hypogonadotropic hypogonadism reveal a key role for neurokinin B in the central control of reproduction. Nat Genet 41:354-358
19. de Roux N, Genin E, Carel JC, Matsuda F, Chaussain JL, Milgrom E 2003 Hypogonadotropic hypogonadism due to loss of function of the KiSS1-derived peptide receptor GPR54. Proc Natl Acad Sci USA 100:10972-10976
20. Bouligand J, Ghervan C, Tello JA, Brailly-Tabard S, Salenave S, Chanson P, Lombès M, Millar RP, Guiochon-Mantel A, Young J 2009 Isolated familial hypogonadotropic hypogonadism and a GNRH1 mutation. N Engl J Med 360:2742-2748
21. Pitteloud N, Meysing A, Quinton R, Acierno Jr JS, Dwyer AA, Plummer L, Fliers E, Boepple P, Hayes F, Seminara S, Hughes VA, Ma J, Bouloux P, Mohammadi M, Crowley Jr WF 2006 Mutations in fibroblast growth factor receptor 1 cause Kallmann syndrome with a wide spectrum of reproductive phenotypes. Mol Cell Endocrinol 254-255:60-69
22. Quinton R, Duke VM, de Zoysa PA, Platts AD, Valentine A, Kendall B, Pickman S, Kirk JM, Besser GM, Jacobs HS, Bouloux PM 1996 The neuroradiology of Kallmann's syndrome: a genotypic and phenotypic analysis. J Clin Endocrinol Metab 81:3010-3017
23. Quinton R, Duke VM, Robertson A, Kirk JM, Matfin G, de Zoysa PA, Azcona C, MacColl GS, Jacobs HS, Conway GS, Besser M, Stanhope RG, Bouloux PM 2001 Idiopathic gonadotrophin deficiency: genetic questions addressed through phenotypic characterization. Clin Endocrinol (Oxf) 55:163-174
24. Hudson R, Laska M, Berger T, Heye B, Schopohl J, Danek A 1994 Olfactory function in patients with hypogonadotropic hypogonadism: an all-or-none phenomenon? Chem Senses 19:57-69
25. Bhagavath B, Podolsky RH, Ozata M, Bolu E, Bick DP, Kulharya A, Sherins RJ, Layman LC 2006 Clinical and molecular characterization of a large sample of patients with hypogonadotropic hypogonadism. Fertil Steril 85:706-713
26. Vogl TJ, Stemmler J, Heye B, Schopoh lJ, Danek A, Bergman C, BalzerJO, Felix R 1994 Kallman syndrome versus idiopathic hypogonadotropic hypogonadism atMRimaging. Radiology 191:53-57
27. Koenigkam-Santos M, Santos AC, Versiani BR, Diniz PR, Junior JE, de Castro M 21 May 2011 Quantitative magnetic resonance imaging evaluation of the olfactory system in Kallmann syndrome: correlation with a clinical smell test. Neuroendocrinology doi: 10.1159/000328437
28. Massin N, Pêcheux C, Eloit C, Bensimon JL, Galey J, Kuttenn F, Hardelin JP, Dodé C, Touraine P 2003 X chromosome-linked Kallmann syndrome: clinical heterogeneity in three siblings carrying an intragenic deletion of the KAL-1 gene. J Clin Endocrinol Metab 88:2003-2008
29. Parenti G, Rizzolo MG, Ghezzi M, DiMaio S, Sperandeo MP, Incerti B, Franco B, Ballabio A, Andria G 1995 Variable penetrance of hypogonadism in a sibship with Kallmann syndrome due to a deletion of the KAL gene. Am J Med Genet 57:476-478
30. Doty RL, Shaman P, Dann M 1984 Development of the University of Pennsylvania Smell Identification Test: a standardized microencapsulated test of olfactory function. Physiol Behav 32:489-502
31. Doty RL 2001 The Smell Identification Test Administration Manual. Haddon Heights, NJ: Sensonics Inc
32. Yousem DM, Geckle RJ, Bilker W, McKeown DA, Doty RL 1996 MR evaluation of patients with congenital hyposmia or anosmia. AJR Am J Roentgenol 166:439-443
33. Sykiotis GP, Plummer L, Hughes VA, Au M, Durrani S, Nayak- Young S, Dwyer AA, Quinton R, Hall JE, Gusella JF, Seminara SB, Crowley Jr WF, Pitteloud N 2010 Oligogenic basis of isolated gonadotropin-releasing hormone deficiency. Proc Natl Acad Sci USA 107:15140-15144
34. Chan YM, de Guillebon A, Lang-Muritano M, Plummer L, Cerrato F, Tsiaras S, Gaspert A, Lavoie HB, Wu CH, Crowley Jr WF, Amory JK, Pitteloud N, Seminara SB 2009 GNRH1 mutations in patients with idiopathic hypogonadotropic hypogonadism. Proc Natl Acad Sci USA 106:11703-11708
35. Bo-Abbas Y, Acierno Jr JS, Shagoury JK, Crowley Jr WF, Seminara SB 2003 Autosomal recessive idiopathic hypogonadotropic hypogonadism: genetic analysis excludes mutations in the gonadotropinreleasing hormone (GnRH) and GnRH receptor genes. J Clin Endocrinol Metab 88:2730-2737
36. Gianetti E, Tusset C, Noel SD, Au MG, Dwyer AA, Hughes VA, Abreu AP, Carroll J, Trarbach E, Silveira LF, Costa EM, de Mendonça BB, de Castro M, Lofrano A, Hall JE, Bolu E, Ozata M, Quinton R, Amory JK, Stewart SE, Arlt W, Cole TR, Crowley WF, Kaiser UB, Latronico AC, Seminara SB 2010 TAC3/TACR3 mutations reveal preferential activation of gonadotropin-releasing hormone release by neurokinin B in neonatal life followed by reversal in adulthood. J Clin Endocrinol Metab 95:2857-2867
37. Martin C, Balasubramanian R, Dwyer AA, Au MG, Sidis Y, Kaiser UB, Seminara SB, Pitteloud N, Zhou QY, Crowley Jr WF 2011 The role of the prokineticin2pathwayinhumanreproduction:evidencefromthestudyof human and murine gene mutations. Endocr Rev 32:225-246
38. Hardelin JP, Dodé C 2008 The complex genetics of Kallmann syndrome: KAL1, FGFR1, FGF8, PROKR2, PROK2, et al. Sex Dev 2:181-193
39. Doty RL, Deems DA, Stellar S 1988 Olfactory dysfunction in Parkinsonism: a general deficit unrelated to neurologic signs, disease stage, or disease duration. Neurology 38:1237-1244
40. Nordin S, Monsch AU, Murphy C 1995 Unawareness of smell loss in normal aging and Alzheimer's disease: discrepancy between selfreported and diagnosed smell sensitivity. J Gerontol B Psychol Sci Soc Sci 50:P187-P192